Randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of etanercept in patients with moderately active rheumatoid arthritis despite DMARD therapy.

Saved in:
Bibliographic Details
Title: Randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of etanercept in patients with moderately active rheumatoid arthritis despite DMARD therapy.
Authors: Hobbs K; Denver Arthritis Clinic, 200 Spruce Street, Suite 100, Denver, CO 80230 USA., Deodhar A; Oregon Health & Science University, 3181 SW Sam Jackson Park Road, Portland, OR 97239 USA., Wang B; Amgen Inc, 1120 Veterans Boulevard, South San Francisco, CA 94080 USA., Bitman B; Amgen Inc, 1120 Veterans Boulevard, South San Francisco, CA 94080 USA., Nussbaum J; Amgen Inc, One Amgen Center Drive, Thousand Oaks, CA 91320 USA., Chung J; Amgen Inc, One Amgen Center Drive, Thousand Oaks, CA 91320 USA., Collier DH; Amgen Inc, One Amgen Center Drive, Thousand Oaks, CA 91320 USA.
Source: SpringerPlus [Springerplus] 2015 Mar 05; Vol. 4, pp. 113. Date of Electronic Publication: 2015 Mar 05 (Print Publication: 2015).
Publication Type: Journal Article
Journal Info: Publisher: SpringerPlus Country of Publication: Switzerland NLM ID: 101597967 Publication Model: eCollection Cited Medium: Print ISSN: 2193-1801 (Print) Linking ISSN: 21931801 NLM ISO Abbreviation: Springerplus Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2193-1801
DOI:10.1186/s40064-015-0895-9